Results 161 to 170 of about 220,141 (335)
Abstract ROS1‐rearranged lung adenocarcinoma is a rare subset of non‐small‐cell lung cancer, typically occurring in young never‐smokers. Its occurrence in very young men with a fluid‐dominant presentation is unusual and may lead to diagnostic pitfalls.
Thanh Thao Nguyen +4 more
wiley +1 more source
Febrile neutropenia associated with adalimumab in a patient with ulcerative colitis
Key Clinical Message Adalimumab has become essential for managing various chronic inflammatory diseases, including inflammatory bowel disease (IBD).
Ma’In Atallah Mohammad Abumuhfouz +3 more
doaj +1 more source
Effect of chamomile on chemotherapy-induced neutropenia: a pilot open-label controlled trial [PDF]
Mahdi Shahriari +4 more
openalex +1 more source
The combination of immune checkpoint inhibitors (ICIs) and radiotherapy synergistically enhances efficacy through an “antigen release‐immune activation” closed‐loop mechanism, significantly improving outcomes in solid tumors (e.g., lung cancer, melanoma).
Guiling Song +5 more
wiley +1 more source
Granulocyte colony-stimulating factors for prevention of febrile neutropenia following chemotherapy: systematic review and meta-analysis [PDF]
Background: Febrile neutropenia (FN) occurs following myelosuppressive chemotherapy and is associated with morbidity, mortality, costs, and chemotherapy reductions and delays.
Akehurst, R. +4 more
core
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre +5 more
wiley +1 more source
GPi‐DBS for SERAC1‐Related Dystonia‐Parkinsonism
Movement Disorders Clinical Practice, EarlyView.
Vidal Yahya +13 more
wiley +1 more source
Graphical abstract summarizing the multifactorial pathogenesis of rheumatoid arthritis (RA) and the therapeutic potential of mesenchymal stromal cell (MSC) therapy. MSCs provide promising benefits through their immunomodulatory properties, low immunogenicity, ability to promote tissue repair, and multi‐lineage differentiation, presenting a potential ...
Yingjia Chen +6 more
wiley +1 more source
Mouse models of neutropenia reveal progenitor-stage-specific defects
David E. Muench +21 more
openalex +2 more sources

